Phenotype
|
Fish
|
Conditions
|
Figures
|
cerebellum Purkinje cell distributed, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6 ,
FIGURE 7
from Wiweger et al., 2021
|
brain mpz expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
olfactory bulb vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
liver npc2.1 expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 1
from Wiweger et al., 2021
|
whole organism mpeg1.1 expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 10
from Wiweger et al., 2021
|
pancreatic acinar cell zymogen granule absent, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 5
from Wiweger et al., 2021
|
whole organism olig1 expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
liver mpx expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
habenular commissure myelination decreased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
brain myelination decreased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
brain il1b expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
liver il1b expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
hepatocyte increased accumulation hepatocyte lipid droplet, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 5
from Wiweger et al., 2021
|
liver inflammatory response increased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
whole organism locomotory behavior decreased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 4
from Wiweger et al., 2021
|
whole organism lgals3a expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 10
from Wiweger et al., 2021
|
habenula structure, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
cerebellum Purkinje cell structure, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
midbrain vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
brain mbpa expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
brain mpeg1.1 expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
liver apoea expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
raphe nucleus vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
pancreatic acinar cell cholesterol increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 5
from Wiweger et al., 2021
|
telencephalon vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
whole organism il1b expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
chemical treatment: beta-cyclodextrin
|
FIGURE 10
from Wiweger et al., 2021
|
whole organism decreased weight, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 1
from Wiweger et al., 2021
|
brain inflammatory response increased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
pancreatic acinar cell inclusion body increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 5
from Wiweger et al., 2021
|
hepatocyte nucleus increased size, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 5
from Wiweger et al., 2021
|
interpeduncular nucleus tegmentum vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
whole organism capn2a expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 10
from Wiweger et al., 2021
|
liver ppp3ca expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
lateral longitudinal fasciculus degeneration, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
heart npc2.1 expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 1
from Wiweger et al., 2021
|
whole organism apoea expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 10
from Wiweger et al., 2021
|
brain capn2a expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
whole organism myelination decreased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
peripheral olfactory organ accumulation peripheral olfactory organ nile blue A, ameliorated
|
npc2.1waw302/waw302 (TL)
|
chemical treatment: beta-cyclodextrin
|
FIGURE 3
from Wiweger et al., 2021
|
liver calcium ion homeostasis process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
fasciculus retroflexus vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
whole organism ppp3ca expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 10
from Wiweger et al., 2021
|
whole organism mbpa expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
whole organism cldnk expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|
cranial nerve II vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
kidney cell degeneration, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 5
from Wiweger et al., 2021
|
whole organism thigmotaxis increased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 4
from Wiweger et al., 2021
|
whole organism decreased length, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 1
from Wiweger et al., 2021
|
cranial nerve I degeneration, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
whole organism mcu expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 10
from Wiweger et al., 2021
|
brain nfkb2 expression increased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
gonad npc2.1 expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 1
from Wiweger et al., 2021
|
spleen npc2.1 expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 1
from Wiweger et al., 2021
|
midbrain myelination decreased process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
hindbrain degeneration, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
brain calcium ion homeostasis process quality, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 9
from Wiweger et al., 2021
|
optic tectum vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 7
from Wiweger et al., 2021
|
medial longitudinal fasciculus degeneration, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
peripheral olfactory organ increased accumulation peripheral olfactory organ nile blue A, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 2 ,
FIGURE 3
from Wiweger et al., 2021
|
habenula vacuolated, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 6
from Wiweger et al., 2021
|
whole organism plp1b expression decreased amount, abnormal
|
npc2.1waw302/waw302 (TL)
|
standard conditions
|
FIGURE 8
from Wiweger et al., 2021
|